Trust Co. of Vermont Acquires New Stake in CVS Health Corporation $CVS

Trust Co. of Vermont bought a new position in CVS Health Corporation (NYSE:CVS) in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 28,800 shares of the pharmacy operator’s stock, valued at approximately $2,979,000.

A number of other hedge funds and other institutional investors also recently modified their holdings of CVS. Elevation Wealth Partners LLC boosted its stake in CVS Health by 41.8% during the second quarter. Elevation Wealth Partners LLC now owns 356 shares of the pharmacy operator’s stock valued at $37,000 after buying an additional 105 shares in the last quarter. Apella Capital LLC raised its position in CVS Health by 1.7% in the second quarter. Apella Capital LLC now owns 6,940 shares of the pharmacy operator’s stock worth $724,000 after acquiring an additional 117 shares in the last quarter. CYBER HORNET ETFs LLC lifted its holdings in CVS Health by 4.1% in the 3rd quarter. CYBER HORNET ETFs LLC now owns 3,442 shares of the pharmacy operator’s stock valued at $259,000 after acquiring an additional 134 shares during the last quarter. Northwestern Mutual Investment Management Company LLC boosted its position in shares of CVS Health by 0.3% during the 4th quarter. Northwestern Mutual Investment Management Company LLC now owns 40,560 shares of the pharmacy operator’s stock valued at $3,219,000 after purchasing an additional 136 shares in the last quarter. Finally, CoreCap Advisors LLC grew its stake in shares of CVS Health by 4.2% in the 2nd quarter. CoreCap Advisors LLC now owns 3,481 shares of the pharmacy operator’s stock worth $360,000 after purchasing an additional 139 shares during the last quarter. Institutional investors own 80.66% of the company’s stock.

Analysts Set New Price Targets

Several research firms recently commented on CVS. Cantor Fitzgerald increased their target price on shares of CVS Health from $100.00 to $110.00 and gave the company an “overweight” rating in a research note on Tuesday, July 7th. Piper Sandler reiterated an “overweight” rating and set a $113.00 price objective on shares of CVS Health in a research report on Monday, June 1st. HSBC reissued a “hold” rating and set a $103.00 price objective on shares of CVS Health in a research note on Monday, July 6th. Robert W. Baird set a $107.00 target price on CVS Health in a research report on Thursday, August 6th. Finally, Wells Fargo & Company increased their price target on CVS Health from $103.00 to $123.00 and gave the company an “overweight” rating in a research report on Monday, July 13th. Twenty-two investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat.com, CVS Health currently has a consensus rating of “Moderate Buy” and an average target price of $106.75.

CVS Health Price Performance

CVS opened at $93.99 on Tuesday. The stock has a fifty day moving average of $102.46 and a 200-day moving average of $88.41. The firm has a market capitalization of $120.21 billion, a P/E ratio of 24.87, a PEG ratio of 0.93 and a beta of 0.61. CVS Health Corporation has a 12-month low of $69.40 and a 12-month high of $110.68. The company has a quick ratio of 0.66, a current ratio of 0.87 and a debt-to-equity ratio of 0.74.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share for the quarter, beating analysts’ consensus estimates of $1.87 by $0.71. The business had revenue of $106.10 billion for the quarter, compared to the consensus estimate of $100.03 billion. CVS Health had a return on equity of 13.12% and a net margin of 1.18%.CVS Health’s revenue for the quarter was up 7.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.81 earnings per share. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. Equities analysts forecast that CVS Health Corporation will post 8.02 EPS for the current fiscal year.

CVS Health Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, August 3rd. Stockholders of record on Thursday, July 23rd were given a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 2.8%. The ex-dividend date of this dividend was Thursday, July 23rd. CVS Health’s dividend payout ratio is 70.37%.

Insider Buying and Selling

In other CVS Health news, Director Larry Robbins sold 1,018,000 shares of the company’s stock in a transaction that occurred on Wednesday, May 20th. The shares were sold at an average price of $93.82, for a total value of $95,508,760.00. Following the transaction, the director owned 5,195,261 shares in the company, valued at approximately $487,419,387.02. This represents a 16.38% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 0.85% of the company’s stock.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over?the?counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in?store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk?in medical clinics and HealthHUB locations that offer expanded clinical services.